Clinical Trials 101: What Every Regulatory Professional Needs to Know
- 0:00 Why Trials Matter to RA
- 7:00 Trial Lifecycle in One View
- 17:00 Who Owns What
Practical shifts you can apply this week
-
Identify the Core Phases, Actors, and Documents in the Clinical Trial Lifecycle
See the full trial flow at a glance so reviews feel less fragmented and handoffs make more sense.
-
Compare Sponsor, CRO, Investigator, IRB/IEC, and Regulator Responsibilities
Clarify who owns what, where oversight sits, and where gaps tend to hide between teams.
-
Evaluate How Protocol Design Choices Affect Safety Oversight, Data Quality, and
Connect design decisions to deviations, feasibility, signal detection, and what reaches the dossier.
-
Diagnose Common Operational and Compliance Risks Across Study Startup, Conduct,
Spot recurring failure points early, from version control drift to thin vendor oversight records.
-
Draft More Targeted Regulatory Questions for Trial Applications, Amendments, and
Leave with sharper questions to ask sponsors and study teams before issues turn into findings.
What we'll cover
-
0:00
Why Trials Matter to RA
Where regulatory decisions meet real study design and conduct, and why late misunderstandings are costly.
-
7:00
Trial Lifecycle in One View
Walk from feasibility to closeout, with the key documents, phase goals, and handoffs along the way.
-
17:00
Who Owns What
Compare sponsor, CRO, investigator, IRB/IEC, and regulator duties. Boundaries matter more than org charts.
-
26:00
Protocol Choices Drive Everything
See how endpoints, visits, and eligibility criteria shape recruitment, deviations, safety, and dataset acceptability.
-
38:00
Startup Submissions and Approvals
Cover CTA, IND, IDE basics, ethics packages, activation sequencing, amendments, and version control.
-
46:00
Conduct, Safety, and Data
Review AE, SAE, and SUSAR pathways, monitoring pressure points, deviations, CAPA, and inspection readiness.
-
56:00
Readouts, Recap, and Questions
Summarize common pitfalls, high-value regulatory questions, and a practical next step for your current study.
Questions people ask before registering
-
It is built for working regulatory professionals who support clinical development, submissions, or inspection readiness. It also fits adjacent roles who need a cleaner view of how trials actually run.
-
No. The session starts with the lifecycle and role basics, then builds toward practical decision points. If you have ever reviewed a trial-related document and wanted more context, you are in the right room.
-
Yes, a replay will be available for registered attendees. So if your calendar does what calendars do, you can still watch it on your own time.
-
Both. Newer attendees get the full map, while experienced professionals get a structured way to spot weak points and ask better questions across applications, amendments, and inspections.
-
If a certificate is offered, the registration or follow-up details will explain how to receive it. This webinar is designed first as practical training you can apply to an active study.
-
Yes. The session uses concrete scenarios, like recruitment-driven protocol amendments, thin CRO oversight records, and safety reporting inconsistencies across regions.